NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Redcliffe Labs

Redcliffe Labs

Private
NoidaHealthcare & Life Scienceshttps://redcliffelabs.com/

Last Round

Series C

Sep 17, 2024

Est. Valuation

$272.3M

Total Funding Raised

$115M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Redcliffe Labs is a diagnostics and precision medicine company that provides reproductive health testing, rare disease assessments, and cancer gene diagnosis, utilizing in-house technology to deliver comprehensive screening services along with counseling and clinical data management.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, E-commerce, Patient Engagement, Telemedicine

Business Model

B2C

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

diagnostic servicespathology testinghome sample collectionpreventive health checkuphealth techradiology servicesdiagnostic labD2C diagnosticscorporate wellnessblood testdigital healthlab test bookingAI-led diagnosticshealth screeningmedical diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Redcliffe Labs Comparables

Compare Redcliffe Labs with similar companies based on industry and business-model similarity.

Redcliffe Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Healthians
95%
Pathkind Labs
88%
Medall Healthcare Pvt. Ltd.
87%

Redcliffe Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CSep 17, 2024
Private EquityJul 6, 2022
Series BMay 6, 2022
Series AApr 1, 2021
SeedMar 21, 2021

Key People

Founding team and executive leadership

Aditya Kandoi

Founder CEO

Founding Team

Pradeep Tomar

Deputy CTO

Executive Team

Alka Saxena

CFO

Executive Team

Redcliffe Labs Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 20, 2026

    Partnered with Roche Diagnostics India to launch a new PCOS blood test.

  • Mar 20, 2026

    Elecsys AMH Plus blood test for PCOS is now available.

Redcliffe Labs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Redcliffe Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Redcliffe Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersNoida
Employee Range2,001
Year Founded2018
Last FundingSep 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.